Adjuvant Therapy for Resected Stage III Melanoma Patients: High-Dose Interferon-Alpha versus Ipilimumab Combined with Kinases Inhibitors
Year: 2012
Type: review
Source: Tumori Journal
Authors: Ettore Minutilli, Claudio Feliciani
Institution: Università Cattolica del Sacro Cuore
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W30375896
